Magdalena Lang is the co-founder and CEO of ProviGenAI, which builds physical-AI software that enables automated biology labs to learn from results and adapt experiments in real time. A medical student and biomedical neuroscientist at the Technical University of Munich, she previously conducted genome-editing research at Harvard Medical School and Boston Children’s Hospital. ProviGenAI has demonstrated up to fivefold reductions in experimental requirements and is working with leading biopharma, CDMO, and research organizations.

‍